Sidus Space Reports Record Q2 2023 Gross Margin
Gross margin nearly doubles to 37% for the quarter ended June 30, 2023, improving 1,800…
Month: August 2023
BioSyent Schedules Q2 and H1 2023 Earnings Release for August 22, 2023
MISSISSAUGA, Ontario, Aug. 15, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
BioSyent Schedules Q2 and H1 2023 Earnings Release for August 22, 2023
MISSISSAUGA, Ontario, Aug. 15, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
NANOBIOTIX Announces Expiration of HSR Waiting Period Regarding the Agreement for Worldwide Co-Development and Commercialization of Potential First-in-Class Radioenhancer NBTXR3
PARIS and CAMBRIDGE, Mass., Aug. 15, 2023 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ:…
NANOBIOTIX Announces Expiration of HSR Waiting Period Regarding the Agreement for Worldwide Co-Development and Commercialization of Potential First-in-Class Radioenhancer NBTXR3
PARIS and CAMBRIDGE, Mass., Aug. 15, 2023 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ:…
Sagimet Biosciences Announces Closing of Underwriters’ Option to Purchase Additional Shares of Series A Common Stock in Connection with its Upsized Initial Public Offering
SAN MATEO, Calif., Aug. 15, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT),…
Sagimet Biosciences Announces Closing of Underwriters’ Option to Purchase Additional Shares of Series A Common Stock in Connection with its Upsized Initial Public Offering
SAN MATEO, Calif., Aug. 15, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT),…
MediWound Reports Second Quarter 2023 Financial Results and Provides Company Update
EscharEx® Phase III study protocol: FDA/EMA-aligned; patient enrollment commencing early 2024; two key research collaborations…
MediWound Reports Second Quarter 2023 Financial Results and Provides Company Update
EscharEx® Phase III study protocol: FDA/EMA-aligned; patient enrollment commencing early 2024; two key research collaborations…
MediWound Announces Collaboration with Mölnlycke on EscharEx® Phase III Study
MediWound joins forces with one of the largest global chronic wound companies in pivotal study…
MediWound Announces Collaboration with Mölnlycke on EscharEx® Phase III Study
MediWound joins forces with one of the largest global chronic wound companies in pivotal study…
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
Approximately 71% of Stockholders Voted in Favor of the TransactionDiffusion Announces 1-for-1.5 Reverse Stock SplitMerger…
MediWound Announces Collaboration with MIMEDX on EscharEx® Phase III Study
MediWound to join forces with leading chronic wound allograft company in pivotal study for patients…
Sanofi: Information concerning the total number of voting rights and shares – July 2023
Information concerning the total number of voting rights and shares, provided pursuant to article L….
As U.S. Cash Balances Reach Record High1, Lincoln Financial Group Enhances Its Best-Selling Registered Indexed-Linked Annuity to Help Protect Against Market Volatility
Dual Performance Trigger and Dual15 Plus available with Lincoln Level Advantage® registered indexed-linked annuity offer…
Verizon response continues on Maui
Talk/Text/Data usage incurred from August 10 – 31 will be waived for Verizon customers on Maui;…
MediaValet Reports Second Quarter 2023 Results
Strong Growth in Revenue (up 30%) and ARR (up 27%) Vancouver, British Columbia–(Newsfile Corp. –…
MediaValet Selected by a Leading EV Charging Network
Vancouver, British Columbia–(Newsfile Corp. – August 15, 2023) – MediaValet Inc. (TSX: MVP) (the Company),…
Datametrex Announces Stock Options Plan
Toronto, Ontario–(Newsfile Corp. – August 15, 2023) – Datametrex AI Limited (TSXV: DM) (FSE: D4G)…
Esports Entertainment Group Announces Registered Direct Offering and Settlement Agreement
St. Julians, Malta–(Newsfile Corp. – August 15, 2023) – Esports Entertainment Group, Inc. (NASDAQ: GMBL)…